Abstract
Despite exciting progress in the understanding and treatment of gout, management of this condition remains suboptimal. In the face of this inadequacy, new guidelines provide recommendations both for therapeutic approaches to hyperuricaemia and for the management and anti-inflammatory prophylaxis of acute gouty arthritis.
MeSH terms
-
Acute Disease
-
Anti-Inflammatory Agents / therapeutic use*
-
Arthritis, Gouty / blood
-
Arthritis, Gouty / drug therapy*
-
Arthritis, Gouty / prevention & control
-
Gout Suppressants / therapeutic use*
-
Humans
-
Hyperuricemia / blood
-
Hyperuricemia / drug therapy*
-
Practice Guidelines as Topic*
-
Randomized Controlled Trials as Topic
-
Rheumatology / methods*
-
Societies, Medical
-
United States
Substances
-
Anti-Inflammatory Agents
-
Gout Suppressants